Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Anat ; 232(5): 721-728, 2018 05.
Article in English | MEDLINE | ID: mdl-29430649

ABSTRACT

The Anatomical Society has developed a series of learning outcomes in consultation with nursing educators delivering anatomical content to undergraduate (preregistration) nursing students. A Delphi panel methodology was adopted to select experts within the field that would recommend core anatomical content in undergraduate nursing programmes throughout the UK. Using the Anatomical Society's Core Gross Anatomy Syllabus for Medical Students as a foundation, a modified Delphi technique was used to develop discipline-specific outcomes to nursing graduates. The Delphi panel consisted of 48 individuals (n = 48) with a minimum of 3 years' experience teaching anatomy to nursing students, representing a broad spectrum of UK Higher Education Institutions. The output from this study was 64 nursing specific learning outcomes in anatomy that are applicable to all undergraduate (preregistration) programmes in the UK. The new core anatomy syllabus for Undergraduate Nursing offers a basic anatomical framework upon which nurse educators, clinical mentors and nursing students can underpin their clinical practice and knowledge. The learning outcomes presented may be used to develop anatomy teaching within an integrated nursing curriculum.


Subject(s)
Anatomy/education , Curriculum/standards , Education, Nursing/standards
2.
Neuroscience ; 290: 300-20, 2015 Apr 02.
Article in English | MEDLINE | ID: mdl-25617654

ABSTRACT

Activity and disuse of synapses are thought to influence progression of several neurodegenerative diseases in which synaptic degeneration is an early sign. Here we tested whether stimulation or disuse renders neuromuscular synapses more or less vulnerable to degeneration, using axotomy as a robust trigger. We took advantage of the slow synaptic degeneration phenotype of axotomized neuromuscular junctions in flexor digitorum brevis (FDB) and deep lumbrical (DL) muscles of Wallerian degeneration-Slow (Wld(S)) mutant mice. First, we maintained ex vivo FDB and DL nerve-muscle explants at 32°C for up to 48 h. About 90% of fibers from Wld(S) mice remained innervated, compared with about 36% in wild-type muscles at the 24-h checkpoint. Periodic high-frequency nerve stimulation (100 Hz: 1s/100s) reduced synaptic protection in Wld(S) preparations by about 50%. This effect was abolished in reduced Ca(2+) solutions. Next, we assayed FDB and DL innervation after 7 days of complete tetrodotoxin (TTX)-block of sciatic nerve conduction in vivo, followed by tibial nerve axotomy. Five days later, only about 9% of motor endplates remained innervated in the paralyzed muscles, compared with about 50% in 5 day-axotomized muscles from saline-control-treated Wld(S) mice with no conditioning nerve block. Finally, we gave mice access to running wheels for up to 4 weeks prior to axotomy. Surprisingly, exercising Wld(S) mice ad libitum for 4 weeks increased about twofold the amount of subsequent axotomy-induced synaptic degeneration. Together, the data suggest that vulnerability of mature neuromuscular synapses to axotomy, a potent neurodegenerative trigger, may be enhanced bimodally, either by disuse or by hyperactivity.


Subject(s)
Neuromuscular Junction/physiopathology , Wallerian Degeneration/physiopathology , Animals , Axotomy , Calcium/metabolism , Electric Stimulation Therapy , Female , Male , Mice, Inbred C57BL , Mice, Transgenic , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neuromuscular Junction/pathology , Running/physiology , Sciatic Nerve/drug effects , Sciatic Nerve/physiopathology , Sodium Channel Blockers/pharmacology , Tetrodotoxin/pharmacology , Tibial Nerve/injuries , Tibial Nerve/physiopathology , Tissue Culture Techniques , Wallerian Degeneration/pathology , Wallerian Degeneration/prevention & control
3.
Neuropathol Appl Neurobiol ; 39(4): 320-34, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23289367

ABSTRACT

Recent developments in our understanding of events underlying neurodegeneration across the central and peripheral nervous systems have highlighted the critical role that synapses play in the initiation and progression of neuronal loss. With the development of increasingly accurate and versatile animal models of neurodegenerative disease it has become apparent that disruption of synaptic form and function occurs comparatively early, preceding the onset of degenerative changes in the neuronal cell body. Yet, despite our increasing awareness of the importance of synapses in neurodegeneration, the mechanisms governing the particular susceptibility of distal neuronal processes are only now becoming clear. In this review we bring together recent developments in our understanding of cellular and molecular mechanisms regulating synaptic vulnerability. We have placed a particular focus on three major areas of research that have gained significant interest over the last few years: (i) the contribution of synaptic mitochondria to neurodegeneration; (ii) the contribution of pathways that modulate synaptic function; and (iii) regulation of synaptic degeneration by local posttranslational modifications such as ubiquitination. We suggest that targeting these organelles and pathways may be a productive way to develop synaptoprotective strategies applicable to a range of neurodegenerative conditions.


Subject(s)
Neurodegenerative Diseases/pathology , Synapses/pathology , Animals , Humans , Mitochondria/pathology , Proteasome Endopeptidase Complex/physiology , Protein Processing, Post-Translational/physiology , Signal Transduction/physiology , Ubiquitin/physiology
4.
Neuromuscul Disord ; 22(5): 435-42, 2012 May.
Article in English | MEDLINE | ID: mdl-22153987

ABSTRACT

Spinal muscular atrophy (SMA) is traditionally described and characterised as a disease of the neuromuscular system. Recently, the vascular system has been implicated in SMA pathogenesis, but there are no reports on whether this impacts on skeletal muscle microvasculature. Using an established mouse model of severe SMA (Smn(-/-);SMN2(+/+)), we examined the capillary bed in three different skeletal muscles using quantitative imaging and western blotting in late symptomatic mice (P5). We found a dramatic (45%) decrease in the density of the capillary bed in all muscles examined compared to littermate controls at early and late symptomatic time points, and reduced expression of a key endothelial protein, PECAM-1. In addition, capillary calibre was increased by 50% in SMA mice while ramification of capillaries into muscle was reduced. Investigation of earlier developmental time points revealed identical changes at an early symptomatic time point (P3), but significantly, no difference at a pre-symptomatic time point (P1). These changes are likely to have considerable impact on the ability of the muscle capillary bed to deliver oxygen and remove metabolites from muscle and may therefore contribute to pathogenesis in SMA.


Subject(s)
Muscular Atrophy, Spinal/pathology , Animals , Animals, Newborn , Disease Models, Animal , Mice , Mice, Knockout , Motor Neurons/metabolism , Motor Neurons/pathology , Muscular Atrophy, Spinal/genetics , Muscular Atrophy, Spinal/metabolism , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Survival of Motor Neuron 1 Protein/genetics
5.
Nat Commun ; 2: 214, 2011.
Article in English | MEDLINE | ID: mdl-21364553

ABSTRACT

A major challenge in neurobiology is to understand mechanisms underlying human neuronal diversification. Motor neurons (MNs) represent a diverse collection of neuronal subtypes, displaying differential vulnerability in different human neurodegenerative diseases. The ability to manipulate cell subtype diversification is critical to establish accurate, clinically relevant in vitro disease models. Retinoid signalling contributes to caudal precursor specification and subsequent MN subtype diversification. Here we investigate the necessity for retinoic acid in motor neurogenesis from human embryonic stem cells. We show that activin/nodal signalling inhibition, followed by sonic hedgehog agonist treatment, is sufficient for MN precursor specification, which occurs even in the presence of retinoid pathway antagonists. Importantly, precursors mature into HB9/ChAT-expressing functional MNs. Furthermore, retinoid-independent motor neurogenesis results in a ground state biased to caudal, medial motor columnar identities from which a greater retinoid-dependent diversity of MNs, including those of lateral motor columns, can be selectively derived in vitro.


Subject(s)
Embryonic Stem Cells/metabolism , Motor Neurons/metabolism , Neurogenesis , Tretinoin/metabolism , Animals , Cell Line , Embryonic Stem Cells/cytology , Humans , Mice , Motor Neurons/cytology , Signal Transduction
6.
Neuromuscul Disord ; 20(11): 740-3, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20637618

ABSTRACT

Neuromuscular pathology is a classic hallmark of many diseases such as muscular dystrophy, myasthenia gravis, amyotrophic lateral sclerosis and spinal muscular atrophy. It is also a feature of many congenital and acquired myopathies and neuropathies such as diabetic neuropathy and toxin-exposure. The availability of experimentally accessible nerve-muscle preparations from rodent models in which pathological events can be studied in nerve and muscle, as well as at the neuromuscular junction, is therefore of fundamental importance for investigating neuromuscular disease. The group of small cranial muscles, which move the ear in the mouse provide ideal experimental preparations for the study of neuromuscular disease in vivo, but information regarding their anatomical and functional characteristics is currently lacking. Here, we provide a detailed description of the levator auris longus, auricularis superior, abductor auris longus and interscutularis muscles. In addition, we briefly review their differential fibre type and developmental characteristics, which can be exploited to aid our understanding of neuromuscular vulnerability and to provide preferable alternatives to more traditional muscle preparations such as gastrocnemius, soleus and diaphragm.


Subject(s)
Muscle, Skeletal/anatomy & histology , Neuromuscular Diseases/pathology , Neuromuscular Junction/anatomy & histology , Animals , Ear , Mice , Muscle, Skeletal/innervation , Muscle, Skeletal/physiology , Neuromuscular Diseases/physiopathology , Neuromuscular Junction/physiology
7.
Neuropathol Appl Neurobiol ; 36(2): 133-56, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20202121

ABSTRACT

Amid the great diversity of neurodegenerative conditions, there is a growing body of evidence that non-somatic (that is, synaptic and distal axonal) compartments of neurones are early and important subcellular sites of pathological change. In this review we discuss experimental data from human patients, animal models and in vitro systems showing that neuromuscular synapses are targeted in different forms of motor neurone disease (MND), including amyotrophic lateral sclerosis and spinal muscular atrophy. We highlight important developments revealing the heterogeneous nature of vulnerability in populations of lower motor units in MND and examine how progress in our understanding of the molecular pathways underlying MND may provide insights into the regulation of synaptic vulnerability and pathology. We conclude that future experiments developing therapeutic approaches specifically targeting neuromuscular synaptic vulnerability are likely to be required to prevent or delay disease onset and progression in human MND patients.


Subject(s)
Motor Neuron Disease/physiopathology , Neuromuscular Junction/physiopathology , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Humans , Muscular Atrophy, Spinal/physiopathology , Synapses/physiology
8.
J Physiol ; 534(Pt 3): 627-39, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11483696

ABSTRACT

This review focuses on recent developments in our understanding of neurodegeneration at the mammalian neuromuscular junction. We provide evidence to support a hypothesis of compartmental neurodegeneration, whereby synaptic degeneration occurs by a separate, distinct mechanism from cell body and axonal degeneration. Studies of the spontaneous mutant Wld(s) mouse, in which Wallerian degeneration is characteristically slow, provide key evidence in support of this hypothesis. Some features of synaptic degeneration in the absence of Wallerian degeneration resemble synapse elimination in neonatal muscle. This and other forms of synaptic plasticity may be accessible to further investigations, exploiting advantages afforded by the Wld(s) mutant, or transgenic mice that express the Wld(s) gene.


Subject(s)
Mice, Mutant Strains/physiology , Neuronal Plasticity/physiology , Synapses/physiology , Wallerian Degeneration/genetics , Wallerian Degeneration/physiopathology , Animals , Mice
9.
Nat Neurosci ; 4(12): 1199-206, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11770485

ABSTRACT

Axons and their synapses distal to an injury undergo rapid Wallerian degeneration, but axons in the C57BL/WldS mouse are protected. The degenerative and protective mechanisms are unknown. We identified the protective gene, which encodes an N-terminal fragment of ubiquitination factor E4B (Ube4b) fused to nicotinamide mononucleotide adenylyltransferase (Nmnat), and showed that it confers a dose-dependent block of Wallerian degeneration. Transected distal axons survived for two weeks, and neuromuscular junctions were also protected. Surprisingly, the Wld protein was located predominantly in the nucleus, indicating an indirect protective mechanism. Nmnat enzyme activity, but not NAD+ content, was increased fourfold in WldS tissues. Thus, axon protection is likely to be mediated by altered ubiquitination or pyridine nucleotide metabolism.


Subject(s)
Axons/metabolism , Fungal Proteins/genetics , Neuromuscular Junction/metabolism , Nicotinamide-Nucleotide Adenylyltransferase/genetics , Recombinant Fusion Proteins/genetics , Saccharomyces cerevisiae Proteins , Trauma, Nervous System , Wallerian Degeneration/genetics , Wallerian Degeneration/metabolism , Action Potentials/genetics , Animals , Axons/ultrastructure , Base Sequence/physiology , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cell Survival/genetics , Fungal Proteins/metabolism , Immunohistochemistry , Mice , Mice, Mutant Strains , Mice, Transgenic , Microscopy, Electron , Molecular Sequence Data , Motor Neurons/cytology , Motor Neurons/metabolism , Muscle, Skeletal/growth & development , Muscle, Skeletal/innervation , Muscle, Skeletal/metabolism , Mutation/physiology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nervous System/metabolism , Nervous System/pathology , Neuromuscular Junction/ultrastructure , Nicotinamide-Nucleotide Adenylyltransferase/metabolism , Recombinant Fusion Proteins/metabolism , Sciatic Nerve/injuries , Sciatic Nerve/metabolism , Sciatic Nerve/ultrastructure , Synaptic Transmission/genetics , Synaptic Vesicles/metabolism , Ubiquitin-Conjugating Enzymes , Wallerian Degeneration/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...